Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
…, D Abramovicz, D Blockmans, A Mathieu… - Arthritis & …, 2002 - Wiley Online Library
Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
…, E De Ramón, M Galeazzi, HJ HAGA, A Mathieu… - Medicine, 1993 - journals.lww.com
Systemic Lupus Erythematosus: Clinical and Immunologic Patte... : Medicine Systemic Lupus
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
…, A Fernández-Nebro, M Galeazzi, M Valen, A Mathieu… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients
…, A Fernández-Nebro, M Galeazzi, HJ Haga, A Mathieu… - Medicine, 1999 - journals.lww.com
… II Cattedra di Reumatologia, Università di Cagliari, Cagliari, Italy: Alessandro Mathieu,
Giuseppe Passiu, Giovanni Sanna, and Alberto Cauli. Service de Rhumatologie, Cliniques …
Giuseppe Passiu, Giovanni Sanna, and Alberto Cauli. Service de Rhumatologie, Cliniques …
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
…, H Laing, MA Khamashta, A Mathieu… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To apply the new American College of Rheumatology nomenclature for
neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalence of the different …
neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalence of the different …
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis …
…, D Abramovicz, D Blockmans, A Mathieu… - Arthritis & …, 2004 - Wiley Online Library
Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …
Overexpression of the cytokine BAFF and autoimmunity risk
…, MG Danieli, S Del Giacco, A Mathieu… - … England Journal of …, 2017 - Mass Medical Soc
Background Genomewide association studies of autoimmune diseases have mapped hundreds
of susceptibility regions in the genome. However, only for a few association signals has …
of susceptibility regions in the genome. However, only for a few association signals has …
Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis
…, M Inanc, L Massardo, A Mathieu… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P
proteins (anti‐P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for …
proteins (anti‐P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for …
The pathogenetic role of HLA-B27 and its subtypes
The strong association between HLA-B27 and ankylosing spondylitis has been known for
more than 33 years, but the enigma of the pathogenetic role of the gene and its product has …
more than 33 years, but the enigma of the pathogenetic role of the gene and its product has …
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
…, E Arrigoni, E Bravi, P Migliorini, A Mathieu… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …